Menu
19/09/2016
Hundreds Of New Jobs To Be Created In Cork
Up to 500 permanent and 800 temporary jobs are to be created in Cork with the establishment of a new biopharmaceutical manufacturing campus.
The Department of Jobs, Enterprise and Innovation has announced that GE are to invest €150 million in a new biopharmaceutical manufacturing campus on Industrial Development Agency (IDA) Ireland's strategic site at Loughbeg, Ringaskiddy.
GE BioPark Cork, subject to contract and planning approvals, will feature Europe's first KUBio, prefabricated, off-the-shelf bio-manufacturing facilities, owned and run by GE customers, and will serve as focal point for further investment in next-generation biopharmaceutical manufacturing in Ireland.
GE BioPark Cork is expected to be home to more than 500 new jobs when fully operational; 400 with biopharma companies and a further 100 employed directly by GE.
The construction phase, subject to planning approvals, is expected to begin by mid-2017 and create up to 800 construction jobs. The project is supported by the Department of Jobs, Enterprise and Innovation through IDA Ireland.
To further develop biopharma manufacturing skills and expertise in Ireland, GE and the National Institute for Bioprocessing Research and Training (NIBRT) also announced today their plan to create a NIBRT-GE Single-use Centre of Excellence at NIBRT's Dublin facility. NIBRT expects to train up to 1,500 bioprocessing professionals annually on next-generation biologic manufacturing technologies. The same state-of-the-art technologies for biopharma manufacturing will be used in GE BioPark Cork's manufacturing facilities. GE BioPark Cork will be a GE-managed campus including four fully-equipped KUBio factories owned by independent biopharma companies manufacturing proprietary medicines, with GE running centralised shared utilities, process development and site services.
Minister for Jobs, Mary Mitchell O'Connor, said: "The Biopharma industry makes a huge contribution to the Irish economy in terms of jobs and manufacturing exports, and is one of the fastest growing sectors. I am delighted that GE is making a significant investment in Cork. This is a further testament to our talented workforce.
"All investment and jobs created has a positive knock on effect on the wider region. Over 28,000 people currently work in biopharma and 6,000 of those work in biologics. This subsector is expected to double in the coming years and will provide both a challenge and an opportunity for the industry and training providers to collaborate on promoting the range of career opportunities available. I welcome GE's commitment to Ireland and wish them every success in the future."
Kieran Murphy, CEO, GE Healthcare Life Sciences, GE Healthcare also said: "Pharma companies world-wide are racing to respond to patient needs with new life-changing biological medicines and GE is investing in technology and service solutions, as well as industry skills and expertise, to enable them to make and get their products to market more quickly. We are delighted to be investing once again in Ireland, where we have ourselves a long history of manufacturing our own medical imaging products."
Martin Shanahan, CEO IDA Ireland, added: "The choice of Ireland for this strategically important investment by GE is a significant win. The biopharmaceutical manufacturing campus will greatly assist IDA Ireland win additional bio-manufacturing investments by acting as a catalyst to attract new innovator drug companies and to transition and grow existing operations.
"Ireland has won more than €10bn in the past 10 years in biotech investment, building on a long history in pharmaceutical manufacturing and is now one of the world's top locations for biopharma, which creates significant secondary employment in construction and other services."
(MH/LM)
The Department of Jobs, Enterprise and Innovation has announced that GE are to invest €150 million in a new biopharmaceutical manufacturing campus on Industrial Development Agency (IDA) Ireland's strategic site at Loughbeg, Ringaskiddy.
GE BioPark Cork, subject to contract and planning approvals, will feature Europe's first KUBio, prefabricated, off-the-shelf bio-manufacturing facilities, owned and run by GE customers, and will serve as focal point for further investment in next-generation biopharmaceutical manufacturing in Ireland.
GE BioPark Cork is expected to be home to more than 500 new jobs when fully operational; 400 with biopharma companies and a further 100 employed directly by GE.
The construction phase, subject to planning approvals, is expected to begin by mid-2017 and create up to 800 construction jobs. The project is supported by the Department of Jobs, Enterprise and Innovation through IDA Ireland.
To further develop biopharma manufacturing skills and expertise in Ireland, GE and the National Institute for Bioprocessing Research and Training (NIBRT) also announced today their plan to create a NIBRT-GE Single-use Centre of Excellence at NIBRT's Dublin facility. NIBRT expects to train up to 1,500 bioprocessing professionals annually on next-generation biologic manufacturing technologies. The same state-of-the-art technologies for biopharma manufacturing will be used in GE BioPark Cork's manufacturing facilities. GE BioPark Cork will be a GE-managed campus including four fully-equipped KUBio factories owned by independent biopharma companies manufacturing proprietary medicines, with GE running centralised shared utilities, process development and site services.
Minister for Jobs, Mary Mitchell O'Connor, said: "The Biopharma industry makes a huge contribution to the Irish economy in terms of jobs and manufacturing exports, and is one of the fastest growing sectors. I am delighted that GE is making a significant investment in Cork. This is a further testament to our talented workforce.
"All investment and jobs created has a positive knock on effect on the wider region. Over 28,000 people currently work in biopharma and 6,000 of those work in biologics. This subsector is expected to double in the coming years and will provide both a challenge and an opportunity for the industry and training providers to collaborate on promoting the range of career opportunities available. I welcome GE's commitment to Ireland and wish them every success in the future."
Kieran Murphy, CEO, GE Healthcare Life Sciences, GE Healthcare also said: "Pharma companies world-wide are racing to respond to patient needs with new life-changing biological medicines and GE is investing in technology and service solutions, as well as industry skills and expertise, to enable them to make and get their products to market more quickly. We are delighted to be investing once again in Ireland, where we have ourselves a long history of manufacturing our own medical imaging products."
Martin Shanahan, CEO IDA Ireland, added: "The choice of Ireland for this strategically important investment by GE is a significant win. The biopharmaceutical manufacturing campus will greatly assist IDA Ireland win additional bio-manufacturing investments by acting as a catalyst to attract new innovator drug companies and to transition and grow existing operations.
"Ireland has won more than €10bn in the past 10 years in biotech investment, building on a long history in pharmaceutical manufacturing and is now one of the world's top locations for biopharma, which creates significant secondary employment in construction and other services."
(MH/LM)
Related Northern Ireland Recruitment News Stories
Click here for the latest headlines.
07 October 2016
600 Manufacturing Jobs Under Threat
The threat to 600 manufacturing jobs at OneSubsea, the Leeds oil and gas engineering firm, reinforces the need for a strong industrial strategy to protect such skilled jobs, Unite the union. Unite said the news that the Houston-based multinational wanted to shed 600 of its 900-strong workforce by the end of 2017 had come "out of the blue".
600 Manufacturing Jobs Under Threat
The threat to 600 manufacturing jobs at OneSubsea, the Leeds oil and gas engineering firm, reinforces the need for a strong industrial strategy to protect such skilled jobs, Unite the union. Unite said the news that the Houston-based multinational wanted to shed 600 of its 900-strong workforce by the end of 2017 had come "out of the blue".
04 September 2014
Magellan Aerospace To Create 47 New Jobs
Enterprise, Trade and Investment Minister Arlene Foster has announced that Magellan Aerospace is investing almost £6million in its Greyabbey operation and creating 47 advanced manufacturing jobs. The Canadian-owned Magellan Aerospace established its presence in Northern Ireland in 2012 when it acquired local company John Huddleston Engineering Ltd.
Magellan Aerospace To Create 47 New Jobs
Enterprise, Trade and Investment Minister Arlene Foster has announced that Magellan Aerospace is investing almost £6million in its Greyabbey operation and creating 47 advanced manufacturing jobs. The Canadian-owned Magellan Aerospace established its presence in Northern Ireland in 2012 when it acquired local company John Huddleston Engineering Ltd.
24 March 2003
De-rating will cost many manufacturing jobs warn MLAs
Alliance Assembly member Sean Neeson has claimed that the Government's proposals to abolish industrial de-rating could cost hundreds of manufacturing jobs in Northern Ireland. The former Deputy Chair of the Assembly's Enterprise, Trade and Investment committee said he would be meeting with the Finance Minister to discuss the matter further.
De-rating will cost many manufacturing jobs warn MLAs
Alliance Assembly member Sean Neeson has claimed that the Government's proposals to abolish industrial de-rating could cost hundreds of manufacturing jobs in Northern Ireland. The former Deputy Chair of the Assembly's Enterprise, Trade and Investment committee said he would be meeting with the Finance Minister to discuss the matter further.
17 June 2016
60 New Jobs Announced For Galway
Medical technology company ZELTIQ Aesthetics has announced that it is to establish its new European manufacturing facility in Galway. Up to 60 new jobs are expected to be created over the next 18 months. The US-based company, headquartered in Pleasanton, California, employs over 600 people on a worldwide basis.
60 New Jobs Announced For Galway
Medical technology company ZELTIQ Aesthetics has announced that it is to establish its new European manufacturing facility in Galway. Up to 60 new jobs are expected to be created over the next 18 months. The US-based company, headquartered in Pleasanton, California, employs over 600 people on a worldwide basis.
26 July 2012
Sangart Announces Plans For New Manufacturing Facility In Ireland
Sangart, Inc., a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen and other gas delivery, today announced plans to build a new manufacturing facility in Ireland.
Sangart Announces Plans For New Manufacturing Facility In Ireland
Sangart, Inc., a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen and other gas delivery, today announced plans to build a new manufacturing facility in Ireland.
-
Northern Ireland WeatherToday:A showery start with outbreaks most frequent north of Lough Neagh and through the morning, before dwindling during the afternoon as the northwest breezes ease and brighter spells of weak sunshine prosper. Maximum temperature 8 °C.Tonight:A dry night, save for a few light showers around the coasts, with prolonged clear spells and light winds bringing a frosty dawn for many in central and southern parts. Minimum temperature -3 °C.
